Ablation of posterior atrial ganglionated plexus potentiates sympathetic tachycardia to behavioral stress.
The role of the posterior atrial ganglionated plexus (PAGP) in heart rate (HR) control was tested in unanesthetized dogs (n = 8). Resting HR was unchanged before (85 +/- 20 beats/min, mean +/- SD) versus after (87 +/- 18 beats/min) surgical ablation of these intrinsic cardiac ganglia (PAGPX). However, the peak tachycardia to a 30-s stressful stimulus was significantly increased (P < 0.05) from +53 +/- 22 beats/min before the denervation to +77 +/- 13 beats/min after PAGPX. Conversely, the peak HR increase during the stress after beta-adrenergic blockade was the same before (36 +/- 24 beats/min) versus after (38 +/- 14 beats/min) PAGPX. Moreover, the HR response to a neutral behavioral stimulus, which is mediated primarily by withdrawal of parasympathetic inhibition of the sinoatrial (SA) node, was unaltered by PAGPX. Thus the augmented tachycardia subsequent to PAGPX was attributable primarily to increased sympathetic action at the SA node. These findings indicate that a major role of PAGP parasympathetic neurons is to inhibit sympathoexcitatory effects on HR, probably either via interactions between neurons comprising the intrinsic plexus(es) or perhaps via presynaptic inhibition of sympathetic neurotransmitter release. This organization would allow parasympathetic ganglia within the PAGP to selectively modify sympathetic input to the SA node independent of direct vagal inhibition of pacemaker activity.
Randall
D C
DC
Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536-0084, USA.
Brown
D R
DR
Li
S G
SG
Olmstead
M E
ME
Kilgore
J M
JM
Sprinkle
A G
AG
Randall
W C
WC
Ardell
J L
JL
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal; D003214:Conditioning, Classical; D003714:Denervation; D004285:Dogs; D004597:Electroshock; D005725:Ganglia, Autonomic / Q000502:physiology*; D006325:Heart Atria / Q000294:innervation*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D013312:Stress, Physiological / Q000503:physiopathology*; D013610:Tachycardia / Q000209:etiology* / Q000503:physiopathology; D014630:Vagus Nerve / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D018727:Muscarinic Antagonists